Skip to main content

and
  1. No Access

    Article

    A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients

    Melanoma reactive CTL were obtained by stimulating PBL from a melanoma patient in remission since 1994 following adjuvant TIL immunotherapy, with the autologous melanoma cell line. They were cloned by limiting...

    Yann Godet, Annabelle Bonnin, Yannik Guilloux in Cancer Immunology, Immunotherapy (2009)